PHARMOS CORP Increase (Decrease) in Accrued Liabilities
PHARMOS CORP reported Increase (Decrease) in Accrued Liabilities of $11.27 thousand for the 9-month period ending 2012-09-30, per its 10-Q filed 2012-11-19.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedLiabilities · last filed 2012-11-19
- PHARMOS CORP increase (decrease) in accrued liabilities for the quarter ending 2012-09-30 was $751.00, a 92.85% decline year-over-year.
- PHARMOS CORP increase (decrease) in accrued liabilities for the quarter ending 2012-06-30 was $29.25K.
- PHARMOS CORP increase (decrease) in accrued liabilities for the quarter ending 2012-03-31 was -$18.73K.
- PHARMOS CORP increase (decrease) in accrued liabilities for the quarter ending 2011-12-31 was -$1.32K.
- PHARMOS CORP increase (decrease) in accrued liabilities for fiscal 2011 was -$5.08K.
- PHARMOS CORP increase (decrease) in accrued liabilities for fiscal 2010 was -$44.50K.
| Period end | Increase (Decrease) in Accrued Liabilities 3 month | Increase (Decrease) in Accrued Liabilities 6 month | Increase (Decrease) in Accrued Liabilities 9 month | Increase (Decrease) in Accrued Liabilities 12 month |
|---|---|---|---|---|
| 2012-09-30 | $751.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-19 | $30.00K derived: sum of 2 quarters · filed 2012-11-19 | $11.27K 10-Q · filed 2012-11-19 | $9.95K derived: sum of 4 quarters · filed 2012-11-19 |
| 2012-06-30 | $29.25K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-07-30 | $10.52K 10-Q · filed 2012-07-30 | $9.20K derived: sum of 3 quarters · filed 2012-07-30 | $19.70K derived: sum of 4 quarters · filed 2012-11-19 |
| 2012-03-31 | -$18.73K 10-Q · filed 2012-04-16 | -$20.05K derived: sum of 2 quarters · filed 2012-04-16 | -$9.55K derived: sum of 3 quarters · filed 2012-11-19 | -$11.74K derived: sum of 4 quarters · filed 2012-11-19 |
| 2011-12-31 | -$1.32K derived: 10-K/A 12 month − 10-Q 9 month · filed 2012-02-21 | $9.18K derived: sum of 2 quarters · filed 2012-11-19 | $6.99K derived: sum of 3 quarters · filed 2012-11-19 | -$5.08K 10-K/A · filed 2012-02-21 |
| 2011-09-30 | $10.50K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-19 | $8.31K derived: sum of 2 quarters · filed 2012-11-19 | -$3.76K 10-Q · filed 2012-11-19 | -$10.81K derived: sum of 4 quarters · filed 2012-11-19 |
| 2011-06-30 | -$2.19K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-07-30 | -$14.26K 10-Q · filed 2012-07-30 | -$21.31K derived: sum of 3 quarters · filed 2012-07-30 | -$23.31K derived: sum of 4 quarters · filed 2012-07-30 |
| 2011-03-31 | -$12.07K 10-Q · filed 2012-04-16 | -$19.12K derived: sum of 2 quarters · filed 2012-04-16 | -$21.12K derived: sum of 3 quarters · filed 2012-04-16 | |
| 2010-12-31 | -$7.05K derived: 10-K/A 12 month − 10-Q 9 month · filed 2012-02-21 | -$9.05K derived: sum of 2 quarters · filed 2012-02-21 | -$44.50K 10-K/A · filed 2012-02-21 | |
| 2010-09-30 | -$2.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-10-31 | -$37.45K 10-Q · filed 2011-10-31 | ||
| 2010-06-30 | -$35.45K 10-Q · filed 2011-08-08 |